bc-ontologyGovernments, institutions, geography and law
Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

21 CFR 314.152 Notice of withdrawal of approval of an application or abbreviated application for a new drug.

21 CFR 314.152 Notice of withdrawal of approval of an application or abbreviated application for a new drug., “Notice of withdrawal of approval of an application or abbreviated application for a new drug”, is a CFR section of 21 CFR Part 314, Subpart D—FDA Action on Applications and Abbreviated Applications; in force.

https://ontology.bommaritollc.com/id/01a0f094-c4d9-70ee-a80b-9fb3b0617fa8
schema:Legislation
Download TurtleJSON-LDN-TriplesMarkdown
Cite this
21 CFR 314.152 Notice of withdrawal of approval of an application or abbreviated application for a new drug.. bc-ontology, release 0.1.0-rc38, 2026-10-21. https://ontology.bommaritollc.com/id/01a0f094-c4d9-70ee-a80b-9fb3b0617fa8

Elsewhere

Facts

adms:identifier
eli:cites
prov:wasDerivedFrom
schema:isPartOf
schema:legislationIdentifier
21 CFR 314.152
schema:legislationJurisdiction
schema:legislationLegalForce
schema:legislationType
schema:name
Notice of withdrawal of approval of an application or abbreviated application for a new drugen
schema:url
skos:prefLabel
21 CFR 314.152 Notice of withdrawal of approval of an application or abbreviated application for a new drug.en

Related

Cited by (1)eli:cites